官方服务：
资源简介：
Array CGH on gemcitabine resistant tumor
应用场景：
创建时间：
2010-06-05
相关数据集
The Genomic Landscape of Response to EGFR Blockade in Colorectal Cancer
Colorectal cancer (CRC) is the third most common cancer world-wide with 1.2 million patients diagnosed yearly. In late stage CRC, the most commonly used targeted therapies are monoclonal antibodies c
NIAID Data Ecosystem70
Whole exome sequencing of A375 melanoma sensitive and resistant cells to BRAF and MEK inhibitors
The dataset include whole exome sequencing of A375 melanoma cell line that is sensitive to BRAF and MEK inhibitors, and A375 cell line-derived resistant clones.
NIAID Data Ecosystem40
Additional file 1 of Pharmacogenomic profiling reveals molecular features of chemotherapy resistance in IDH wild-type primary glioblastoma
Additional file 1: Table S1. Clinical annotations of 128 GBM samples used in the study. Table S2. Variants identified by WES and GliomaSCAN. Table S3. Copy number alteration by WES and/or RNA-seq. Tab
Figshare2023-03-13 更新30
Array CGH on gemcitabine resistant tumor
Biological material: One solid mouse tumor "Colon 26A" was routinely maintained by successive transplantation. A subset of mice with this tumor was treated at the maximum tolerable dosage of Gemcitabi
NIAID Data Ecosystem50
Homo sapiens Raw sequence reads. Homo sapiens
These are 6-ethylthioinosine-resistant and non-resistant Primary Effusion Lymphoma (PEL) subclones of the BC-3 cell line.
NIAID Data Ecosystem30
